Nevro Corp (NYSE:NVRO) price on Friday, January 17, rose 1.56% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.57.
A look at the stock’s price movement, the close in the last trading session was $4.50, moving within a range at $4.44 and $4.65. The beta value (5-Year monthly) was 0.931. Turning to its 52-week performance, $19.47 and $3.16 were the 52-week high and 52-week low respectively. Overall, NVRO moved 10.12% over the past month.
Nevro Corp’s market cap currently stands at around $171.24 million, with investors looking forward to this quarter’s earnings report slated for in February.
Analysts have a consensus estimate of 101.34M for the company’s revenue for the quarter, with a low and high estimate of 99.7M and 105.65M respectively. The average forecast suggests down to a -12.77% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 404.24M, representing a -4.92% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NVRO is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
15 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 6 analyst(s) rate the stock as a Hold, 7 recommend NVRO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 2 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
NVRO’s current price about 19.17% and 7.79% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.52, while 7-day volatility ratio is 11.47% and 8.69% in the 30-day chart. Further, Nevro Corp (NVRO) has a beta value of 0.87, and an average true range (ATR) of 0.35. Analysts have given the company’s stock an average 52-week price target of $5.5, forecast between a low of $4 and high of $7. Looking at the price targets, the low is 12.47% off current price level while to achieve the yearly target high, price needs to move -53.17%. Nonetheless, investors will most likely welcome a -20.35% jump to $5.5 which is the analysts’ median price.
If we refocus on Nevro Corp (NYSE:NVRO), historical trading data shows that trading volumes averaged 0.73 over the past 10 days and 574.18K over the past 3 months. The company’s latest data on shares outstanding shows there are 37.44 million shares.
The 5.65% of Nevro Corp’s shares are in the hands of company insiders while institutional holders own 98.85% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.75 million on 2024-12-31, giving us a short ratio of 6.52. The data shows that as of 2024-12-31 short interest in Nevro Corp (NVRO) stood at 846.9999999999999 of shares outstanding, with shares short falling to 2.8 million registered in 2024-11-29. Current price change has pushed the stock 22.85% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NVRO stock continues to rise going into the next quarter.
